DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for spermatocele — screening already-approved drugs against its 34-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleSpermatocele maps to a 34-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for spermatocele is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
protein kinase cGMP-dependent 1 (PRKG1) — PRKG1 is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet anpdrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 7LV3 · 2.41 Å · ligand PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER (ANP). Experimental structure, not a prediction.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Microsurgery · 1984 · 0 citations
A new type of alloplastic spermatocele: The bridge spermatocele
AbstractA new type of artificial spermatocele is proposed. A Gore-tex cylinder is sutured to the tails of the epididymides making a bridge between the two testes. The advantages of this spermatocele are (1) use of a single puncture; (2) easy execution of the puncture because the bridge stabilizes and holds the testicles in place; (3) a greater quantity of aspirate and, therefore, easier conservation of sperm; (4) a better quality of aspirate; and (5) relative ease of the surgical procedure.
Do sperm reservoirs still have a place in male infertility management?
AbstractAdvances in reproductive medicine require the periodic revision of therapeutic methods. The emergence of assisted reproductive techniques has resulted in a new turn in the therapeutic aims of andrology. Therefore, in contrast with previous attempts to achieve a higher sperm count and better sperm motility, individual spermatozoa and their de-novo utilization have gained significance. Accordingly, reassessment of the role of artificial and alloplastic spermatocele, offering an alternative solution for the management of obliterative azoospermia, is topical.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
